Cite

HARVARD Citation

    Riera, P. et al. (2018). Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer. Pharmacogenomics journal. 18 (4), pp. 556-564. [Online]. 
  
Back to record